Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12-Week, Multicenter, Open-Label, Single-Arm Study To Evaluate The Effects Of Fesoterodine On Treatment Satisfaction And Symptom Relief In Overactive Bladder Patients.

NCT00425100 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00425100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00425100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12-Week, Multicenter, Open-Label, Single-Arm Study To Evaluate The Effects Of Fesoterodine On Treatment Satisfaction And Symptom Relief In Overactive Bladder Patients.
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2007
Completion date
October 31, 2007
Enrollment
516 (actual)
Sites
60

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder